EnBW Energie Baden-Württemberg AG (FRA:EBK)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	23,293	16,251	21,452	23,564	20,585	15,168
Market Cap Growth	-3.48%	-24.24%	-8.97%	14.47%	35.71%	10.89%
Enterprise Value	42,312	33,936	34,478	36,108	31,405	27,667
PE Ratio	23.41	13.07	13.95	13.56	56.68	25.45
PS Ratio	0.67	0.47	0.48	0.42	0.64	0.76
PB Ratio	1.26	0.92	1.35	1.85	2.42	1.95
P/FCF Ratio	-	-	-	-	3.93	-
P/OCF Ratio	5.99	6.20	23.84	13.06	2.71	13.10
EV/Sales Ratio	1.22	0.97	0.77	0.64	0.97	1.39
EV/EBITDA Ratio	13.40	11.14	17.87	12.78	12.49	11.25
EV/EBIT Ratio	32.52	21.86	77.97	25.85	27.51	22.53
EV/FCF Ratio	-22.74	-	-	-	6.00	-
Debt / Equity Ratio	1.13	1.17	1.10	1.08	1.43	1.35
Debt / EBITDA Ratio	6.84	6.37	8.27	4.61	4.52	4.03
Debt / FCF Ratio	-	-	-	-	2.32	-
Quick Ratio	1.09	1.00	0.78	0.48	0.40	0.60
Current Ratio	1.53	1.54	1.39	1.13	1.05	1.08
Asset Turnover	0.53	0.54	0.67	0.80	0.55	0.45
Return on Equity (ROE)	9.00%	10.85%	12.80%	17.34%	5.42%	10.62%
Return on Assets (ROA)	1.15%	1.50%	0.41%	1.24%	1.22%	1.72%
Return on Capital (ROIC)	2.04%	2.70%	0.92%	3.70%	3.67%	4.44%
Return on Capital Employed (ROCE)	2.40%	3.10%	0.90%	3.40%	3.10%	3.60%
Earnings Yield	4.27%	7.65%	7.17%	7.38%	1.76%	3.93%
Earnings Yield	4.27%	7.65%	7.17%	7.38%	1.76%	3.93%
FCF Yield	-7.99%	-17.62%	-16.34%	-4.10%	25.44%	-6.73%
Dividend Yield	2.32%	2.76%	2.09%	1.41%	1.61%	2.00%
Payout Ratio	57.45%	51.23%	27.13%	22.98%	98.13%	65.27%
Total Shareholder Return	2.32%	2.76%	2.09%	1.41%	1.61%	2.00%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.